NR3C1 and arthritic joint disease: Amelioration of arthritis symptoms by promoting tissue formation and reducing gene expression of inflammatory cytokines in the synovium via inactivation of TLR and NF-κB signalling pathways and down-regulation of leukotrienes (LTB4) through the glucocorticoid receptor.